As of 2024-12-11, the Intrinsic Value of Bioventix PLC (BVXP.L) is
4,768.10 GBP. This BVXP.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 3,650.00 GBP, the upside of Bioventix PLC is
30.60%.
The range of the Intrinsic Value is 3,424.00 - 8,322.58 GBP
4,768.10 GBP
Intrinsic Value
BVXP.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
3,424.00 - 8,322.58 |
4,768.10 |
30.6% |
DCF (Growth 10y) |
4,110.46 - 9,463.00 |
5,588.44 |
53.1% |
DCF (EBITDA 5y) |
2,208.78 - 2,920.60 |
2,284.40 |
-37.4% |
DCF (EBITDA 10y) |
2,954.37 - 3,892.54 |
3,129.46 |
-14.3% |
Fair Value |
1,425.69 - 1,425.69 |
1,425.69 |
-60.94% |
P/E |
1,036.57 - 2,490.25 |
1,628.42 |
-55.4% |
EV/EBITDA |
1,593.24 - 2,845.11 |
1,627.33 |
-55.4% |
EPV |
1,918.76 - 2,424.29 |
2,171.52 |
-40.5% |
DDM - Stable |
1,173.47 - 3,414.07 |
2,293.77 |
-37.2% |
DDM - Multi |
1,855.34 - 3,836.41 |
2,465.38 |
-32.5% |
BVXP.L Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
190.52 |
Beta |
-0.03 |
Outstanding shares (mil) |
0.05 |
Enterprise Value (mil) |
185.01 |
Market risk premium |
5.98% |
Cost of Equity |
10.14% |
Cost of Debt |
5.00% |
WACC |
7.15% |